And here we get to the main results Of the patients (53) treated with remsevidir, most improved! The death rate also appears to have been pretty low at only 13% (7/53)pic.twitter.com/8VogvKfDxU
You can add location information to your Tweets, such as your city or precise location, from the web and via third-party applications. You always have the option to delete your Tweet location history. Learn more
Let's sum up:
very small retrospective trial
no control group
written by pharma funder
high dropout
short timeframe
missing data
poorly written/edited
somewhat odd stats
highly selected patient cohort
no causal conclusions!
Basically, it was a very small study with HUGE caveats that showed an interesting possibility Hard to say anything more than that without a proper trial of some kind
Some might argue that this should not have been published as a research trial, given the many caveats and huge conflicts of interest this study seems to contain
I guess that's a question for @NEJM, who appear to have garnered millions of reads on the article in the last few days
Why wasn't this published as a research note instead?
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.